Advertisement

As rich nations race ahead, Africa barely makes a dent with COVID vaccinations

Health worker preparing dose of COVID-19 vaccine
A health worker prepares a dose of the Pfizer COVID-19 vaccine at a clinic near Johannesburg, South Africa.
(Themba Hadebe / Associated Press)
Share via

In the global race to vaccinate people against COVID-19, Africa is tragically at the back of the pack.

In fact, it has barely gotten out of the starting blocks.

In South Africa, which has the continent’s most robust economy and its biggest coronavirus caseload, just 0.8% of the population is fully vaccinated, according to a worldwide tracker kept by Johns Hopkins University. And hundreds of thousands of the country’s health workers, many of whom come face to face with the virus every day, are still waiting for their shots.

In Nigeria, Africa’s most populous country, only 0.1% of its more than 200 million people are fully protected. The proportion in Kenya, with 50 million people, is even lower. Uganda has recalled doses from rural areas because it doesn’t have nearly enough to fight outbreaks in big cities.

Advertisement

Chad didn’t administer its first vaccine shots until last weekend. And there are at least five other countries in Africa where not one dose has been put into an arm, according to the Africa Centers for Disease Control and Prevention.

The World Health Organization says the continent of 1.3 billion people is facing a severe shortage of vaccine at the same time a new wave of infections is rising across Africa. Vaccine shipments into Africa have ground to a “near halt,” the WHO said last week.

The U.S. is unlikely to meet President Biden’s target to have 70% of Americans at least partially vaccinated by July 4.

“It is extremely concerning and at times frustrating,” said Africa CDC Director Dr. John Nkengasong, a Cameroonian virologist who is trying to ensure that some of the world’s poorest nations get a fair share of vaccines in a marketplace where they can’t possibly compete.

Advertisement

The United States and Britain, by contrast, have fully vaccinated more than 40% of their populations, with higher rates for adults and high-risk people. Countries in Europe are near or past 20% coverage, and their citizens are starting to think about where their vaccine certificates might take them on summer vacation. The U.S., France and Germany are even offering shots to youngsters, who are at very low risk of serious illness from COVID-19.

Poorer countries had warned as far back as last year of this impending vaccine inequality, fearful that rich nations would hoard doses.

In an interview, Nkengasong called on the leaders of wealthy nations meeting this week at the G-7 summit to share spare vaccines — something the United States has already agreed to do — and avert a “moral catastrophe.”

Advertisement

Experts said that while the pause on Johnson & Johnson’s vaccine may make sense for the U.S., stoppages in poorer countries would end up costing lives.

“I’d like to believe that the G-7 countries, most of them having kept excess doses of vaccines, want to be on the right side of history,” Nkengasong said. “Distribute those vaccines. We need to actually see these vaccines, not just ... promises and goodwill.”

Others are not so patient, nor so diplomatic.

“People are dying. Time is against us. This IS INSANE,” South African human rights lawyer Fatima Hasan, an activist for equal access to healthcare, wrote in a series of text messages.

The Biden administration made its first major move to ease the crisis last week, announcing that it would share an initial batch of 25 million spare doses with desperate countries in South and Central America, Asia and Africa.

Biden supports relaxing global trade restrictions for COVID-19 vaccines so that more countries can produce them and bring a faster end to the pandemic.

Nkengasong and his team were in contact with White House officials a day later, he said, with a list of countries where the 5 million doses earmarked for Africa could go to immediately.

Still, the U.S. offer is only a “trickle” of what’s needed, Hasan wrote.

Africa is facing a shortfall of around 700 million doses, even after taking into account those secured through the WHO’s vaccine program for poorer countries, COVAX, and a deal with Johnson & Johnson, which comes through in August, two long months away.

Uganda just released a batch of 3,000 vaccine doses in the capital, Kampala — a minuscule amount for a city of 2 million — to keep its program barely intact.

Advertisement

There and elsewhere, the fear is that the luck that somehow enabled parts of Africa to escape the worst of previous waves of COVID-19 infections and deaths might not hold this time.

“The first COVID was a joke, but this one is for real. It kills,” said Danstan Nsamba, a taxi driver in Uganda who has lost numerous people he knew to the disease.

In Zimbabwe, Chipo Dzimba embarked on a quest for a vaccine after witnessing COVID-19 deaths in her community. She walked miles to a church mission hospital, where there were none, and miles again to a district hospital, where nurses also had nothing and told her to go to the region’s main government hospital. That was too far away.

“I am giving up,” Dzimba said. “I don’t have the bus fare.”

Poor countries face long waits for injections as the U.S. and others buy up nearly all the global supply of Pfizer and Moderna vaccines.

South African health workers faced similar disappointment when they crowded into a parking garage last month, hoping for vaccinations and ignoring social-distancing protocols in their desperation. Many came away without receiving a shot.

Femada Shamam, who is in charge of a group of retirement homes in the South African city of Durban, has seen only about half of the 1,600 older and frail people she looks after vaccinated.

“They do feel very despondent and they do feel let down,” Shamam said of her unvaccinated residents, who are experiencing “huge anxiety” as they hunker down in their sealed-off homes 18 months into the outbreak. Twenty-two of her residents have died of COVID-19.

Advertisement

“It really highlights the biggest problem ... the haves and the have-nots,” Shamam said.

As for whether wealthy countries with surplus vaccine doses have gotten the message, Nkengasong said: “I am hopeful, but not necessarily confident.”

Advertisement